COMMUNIQUÉS West-GlobeNewswire

Mainz Biomed and OncoVanguard8 Enter into Agreement to bring ColoAlert to South America
18/11/2025
OncoVanguard8 is a leading service provider for innovative healthcare products for insurance companies operating in Peru, Colombia and Ecuador BERKELEY, Calif. and MAINZ, Germany, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Mainz [...]
Inspire Medical Systems, Inc. to Present at the Piper Sandler 37th Annual Healthcare Conference
18/11/2025
MINNEAPOLIS, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive [...]
Entera Bio to Participate in the 8th Annual Evercore ISI Healthcare Conference
18/11/2025
JERUSALEM, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (Nasdaq: ENTX), (“Entera” or the “Company”) a leader in the development of oral peptide and protein replacement therapies, today announced that the Company’s [...]
Nasus Pharma Announces Initiation of Phase 2 Clinical Study of NS002 with First Participant Dosed
18/11/2025
The Phase 2 study is designed to address regulatory approval considerations by comparing bioavailability and pharmacokinetics of NS002 against EpiPen Previous clinical study demonstrated NS002 can achieve faster and [...]
INmune Bio Announces Two Presentations at the Upcoming 18th Annual CTAD Conference
18/11/2025
Boca Raton, FL, Nov. 18, 2025 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage inflammation and immunology company, today announces two presentations at the upcoming 18th Clinical Trials on [...]
MBX Biosciences to Participate in the 37th Annual Piper Sandler Healthcare Conference
18/11/2025
CARMEL, Ind., Nov. 18, 2025 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc. (Nasdaq: MBX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the [...]
CytoMed Therapeutics Completes Acquisition of T Cell Technology from UK to Treat Cancers in China and India
18/11/2025
SINGAPORE, Nov. 18, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary novel [...]
Synergy CHC Corp. (NASDAQ: SNYR) Adds Five New Direct Store Delivery Partners, Expanding FOCUSfactor Functional Beverage Distribution to Ten States Nationwide
18/11/2025
WESTBROOK, Maine, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (NASDAQ: SNYR) (“Synergy” or the “Company”), a leading consumer health and wellness company, today announced the addition of five new Direct Store [...]
Emergent BioSolutions Marks 10-Year Anniversary of the U.S. FDA Approval of NARCAN® Nasal Spray and Reinforces its Commitment to Increasing Naloxone Access
18/11/2025
GAITHERSBURG, Md., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Today Emergent BioSolutions (NYSE: EBS) recognizes the 10-year anniversary of the U.S. Food and Drug Administration (FDA) approval of NARCAN ® (naloxone HCl) Nasal [...]
Nanox Announces Strategic Partnership with 3DR® Labs to Expand AI-Powered Imaging Solutions Across North America
18/11/2025
3DR ® Labs to Offer Nanox.AI’s FDA-Cleared Imaging Solutions to Its Network of More Than 1,800 Hospitals and Imaging Centers Across the U.S. PETACH TIKVA, Israel, Nov. 18, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD (“ [...]
Catheter Precision Announces Third VIVO Installation in France
18/11/2025
First-ever multi-year agreement highlights commitment to French electrophysiology market FORT MILL, S.C., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (VTAK - NYSE/American), a US based medical device [...]
Annovis Announces FDA Meeting to Discuss Parkinson's Disease Dementia Program; Reaffirms FDA Alignment on Pivotal Phase 3 Alzheimer's Disease Study
18/11/2025
MALVERN, Pa., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases [...]
Acumen Pharmaceuticals to Present on Recruitment Strategies for Phase 2 ALTITUDE-AD Trial and Enhanced Brain Delivery Technology at 18th Annual Clinical Trials on Alzheimer’s Disease (CTAD) Conference
18/11/2025
NEWTON, Mass., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta oligomers (AβOs) [...]
ProPhase Labs, Inc. to Present Third Quarter 2025 Financial Results on November 19
18/11/2025
UNIONDALE, NY, Nov. 18, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH) (the “Company” or “ProPhase”), a next generation biotech, genomics and consumer products company, announced today that they will be [...]
Rakovina Therapeutics’ President & CSO to Present and Join Expert Panel at the 9th Annual DDR Inhibitors Summit
18/11/2025
VANCOUVER, British Columbia, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV)(FSE: 7JO0) a biopharmaceutical company advancing cancer therapies through AI-enabled [...]
A natural breakthrough in protecting cereals and field crops
18/11/2025
Syngenta and Amoeba SA to develop and commercialize biocontrol solutions for EU and UK Chassieu, France Basel, Switzerland , Nov. 18, 2025 (GLOBE NEWSWIRE) -- Amoebas. These single-celled microorganisms are now at the [...]
Uma inovação natural na proteção de cereais e culturas agrícolas
18/11/2025
Syngenta e Amoéba SA vão desenvolver e comercializar soluções de biocontrolo na UE e no Reino Unido Basileia, Suíça Chassieu, França, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Uma inovação natural na proteção de cereais e [...]
HelixAI launches a new agentic operating system to bring the power of autonomous AI to life sciences
18/11/2025
PRESS RELEASE New operating system enables scientists to move from copilot to autopilot, unifying diverse in silico, wet lab research and scientists to accelerate innovation Partnerships with NVIDIA, AWS and Sapio [...]
Zymeworks Appoints Scott Platshon as Acting Chief Investment Officer
18/11/2025
VANCOUVER, British Columbia, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets, while developing a diverse pipeline of novel, [...]

Pages